Newsletter Spring 2023

Mississippi Cancer Registry

March 2023

Volume 18 Issue 1

CODING TIP – PRIMARY SITE FOR BREAST

There is often conflicting information when trying to determine the primary site code for a breast primary malignancy. 

Solid Tumor Rules 2023 for breast tells us to refer to the “clock diagram” for terms and definitions and the Seer Manual for a priority list for using documents. 

SEER Manual Appendix C Coding Breast Guidelines 2023 states:

Use the information from reports in the following priority order to code a subsite when there is conflicting information:

1. Operative report
2. Pathology report
3. Mammogram, ultrasound (ultrasound becoming more frequently used)
4. Physical examination

NEW FOR 2023

Solid Tumor Rules have been updated for 2023.  SEER provides the 2023 Solid Tumor Modules, links to previous versions, and change log.  Janet Vogel of Omega Healthcare provided this example of a histology coding change for lung in her recent Tumor Talk webinar “What’s New for 2023”.  (We highly recommend watching this webinar!)

 Scenario: 2023 Lung Bx: High grade neuroendocrine carcinoma  Question: How would you code histology?

8240 Carcinoid tumor, NOS/Well-differentiated neuroendocrine carcinoma

8041 small cell carcinoma/neuroendocrine tumors (NET Tumors)

8246 Neuroendocrine carcinoma nos

Answer & Rationale - 8246 Neuroendocrine carcinoma nos Rationale: Lung Solid Tumor Rules 2023 Update

This change is specifically mentioned in the change log linked at the bottom of the 2023 Solid Tumor Modules referenced above.

For any questions please contact Lisa Hamel, RHIA, CTR - lhamel@umc.edu                               

MCRA SPRING MEETING

UMMC Conference Center @ Jackson Medical Mall

April 20^th, 2023

8AM— 5PM

8:00 – 8:45 Breakfast/Registration

8:45 – 8:50 Welcome/Introduction

8:50 – 9:50 Prostate Cancer

9:50 – 10:00 Break

10:00 – 11:00 Gastric Cancer

11:00 – 12:00 Liver Cancer

12:00 – 1:30 Lunch/Business Meeting

1:30 – 2:30 Radiation Oncology

2:30 – 3:30 SSDIs (Jennifer Ruhl)

3:30 – 3:40 Break

3:40 – 4:40 Solid Tumor Rules (Lois Dickie)

4:40 – 4:45 Conclusion

FOR MORE INFORMATION CONTACT:

Sarah Patrick at—SKPATRICK@UMC.EDU Or

Angel Davis at—ADAVIS6@UMC.EDU

ABSTRACTING RESOURCES

AJCC Cancer Staging Manual

Cases with a diagnosis date of 01/01/2018 and forward should be staged using AJCC 8th Edition Cancer Staging Manual. The 3rd printing 2018 Edition is now available.

Please visit https://cancerstaging.org/references-tools/deskreferences/Pages/8EUpdates.aspx# for all 8th Edition updates and corrections. For all other information, visit https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/.

Summary Stage 2018

The 2018 version of Summary Stage applies to every site and/or histology combination, including lymphomas and leukemias. Summary Stage uses all information available in the medical record; in other words, it is a combination of the most precise clinical and pathological documentation of the extent of disease. The Summary Stage 2018 manual is available at https://seer.cancer.gov/tools/ssm/.

Site Specific Data Items (SSDI)

Site Specific Data Items (SSDI) are similar to the Site Specific Factors (SSF) collected with Collaborative Stage. These data items are specific to certain site/histology combinations. For example, the SSDI’s for breast will be used to collect information such as estrogen receptor status, progesterone receptor status, Her2 status, Nottingham grade, and additional information related to primary tumors of the breast. The information collected in these data items are specific to breast. The SSDI manual is available at https://apps.naaccr.org/ssdi/list/.

Grade

Beginning with cases diagnosed in 2018 grade information will be collected in three fields; Clinical Grade, Pathological Grade, and Post-Therapy Grade. Within the Grade Manual you will find definitions for the three new grade data items, coding instructions, and the site/histology specific grade tables. The Grade manual is available at https://www.naaccr.org/SSDI/Grade-Manual.pdf?v=1527859766.

SEER Hematopoietic and Lymphoid Neoplasm Database

This provides data collection rules for hematopoietic and lymphoid neoplasms for 2010+. The SEER Hematopoietic and Lymphoid Neoplasm manual is available at https://seer.cancer.gov/tools/heme/ Hematopoietic_Instructions_and_Rules.pdf.

Solid Tumor Coding Manual

Use the 2018 Solid Tumor coding rules to determine the number of primaries to abstract and the histology to code for cases diagnosed 2018 and forward. The Solid Tumor coding rules replace the 2007 Multiple Primary and Histology (MP/H) Rules. The manual is available at https://seer.cancer.gov/tools/solidtumor/. The change log contains updates made to the FINAL module sections. This does not include changes made to the drafts.

STORE Manual

The STORE Manual has replaced the FORDS Manual. The STORE is now available at https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/ncdb-call-for-data/registry-manuals/.

MCR STAFF

Director UMMC & MCR: Deirdre Rogers, dbrogers@umc.edu

MCR Manager: Angel Davis, adavis6@umc.edu

Clinical Systems Analyst-Intermediate: Tresheena Boyd, tboyd@umc.edu

Data Quality Analyst–Trainer: Lisa Hamel, lhamel@umc.edu

Data Quality Analyst-Auditor: April Wright, ahuggins@umc.edu

Cancer Registrars:                                            

Stacy Major, semajor@umc.edu                      

Laken A. Frederick, lfrederick@umc.edu

Madeline N. Hall, mnhall@umc.edu

Mallory R. Israel, misrael@umc.edu

Administrative Assistant:

Michelle Smith, mrsmith2@umc.edu

University of MS Medical Center

2500 North State Street

Jackson, MS 39216

Phone: 601-815-5482

Fax: 601-815-5483